Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
21098 | 373 | 31.4 | 55% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
1613 | 6524 | TOXICOGENOMICS//BENCHMARK DOSE//GENOTOXIC IMPURITIES |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | GENOTOXIC IMPURITIES | Author keyword | 41 | 68% | 10% | 36 |
2 | VIRACEPT | Author keyword | 12 | 86% | 2% | 6 |
3 | ANALYTICAL CONTROL STRATEGY | Author keyword | 4 | 75% | 1% | 3 |
4 | NELFINAVIR MESILATE | Author keyword | 4 | 75% | 1% | 3 |
5 | CHICAGO PHARMACEUT SCI GRP | Address | 3 | 100% | 1% | 3 |
6 | NOGEL | Author keyword | 3 | 100% | 1% | 3 |
7 | DRUG DISPOSIT PRECLIN SAFETY ANIM | Address | 2 | 67% | 1% | 2 |
8 | GENETIC SAFETY | Author keyword | 2 | 67% | 1% | 2 |
9 | MUTATION THRESHOLD | Author keyword | 2 | 67% | 1% | 2 |
10 | VITRY ALFORTVILLE | Address | 2 | 40% | 1% | 4 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | GENOTOXIC IMPURITIES | 41 | 68% | 10% | 36 | Search GENOTOXIC+IMPURITIES | Search GENOTOXIC+IMPURITIES |
2 | VIRACEPT | 12 | 86% | 2% | 6 | Search VIRACEPT | Search VIRACEPT |
3 | ANALYTICAL CONTROL STRATEGY | 4 | 75% | 1% | 3 | Search ANALYTICAL+CONTROL+STRATEGY | Search ANALYTICAL+CONTROL+STRATEGY |
4 | NELFINAVIR MESILATE | 4 | 75% | 1% | 3 | Search NELFINAVIR+MESILATE | Search NELFINAVIR+MESILATE |
5 | NOGEL | 3 | 100% | 1% | 3 | Search NOGEL | Search NOGEL |
6 | GENETIC SAFETY | 2 | 67% | 1% | 2 | Search GENETIC+SAFETY | Search GENETIC+SAFETY |
7 | MUTATION THRESHOLD | 2 | 67% | 1% | 2 | Search MUTATION+THRESHOLD | Search MUTATION+THRESHOLD |
8 | SULFONATE ESTERS | 2 | 29% | 1% | 5 | Search SULFONATE+ESTERS | Search SULFONATE+ESTERS |
9 | 1 3 DIISOPROPYLUREA | 1 | 100% | 1% | 2 | Search 1+3+DIISOPROPYLUREA | Search 1+3+DIISOPROPYLUREA |
10 | 4 CHLORO 1 BUTANOL | 1 | 100% | 1% | 2 | Search 4+CHLORO+1+BUTANOL | Search 4+CHLORO+1+BUTANOL |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | GENOTOXIC IMPURITIES | 15 | 73% | 3% | 11 |
2 | INGREDIENTS APIS | 11 | 100% | 2% | 6 |
3 | DRUG SUBSTANCES | 8 | 27% | 7% | 25 |
4 | POTENTIAL GENOTOXIC IMPURITIES | 3 | 100% | 1% | 3 |
5 | GC MS METHOD | 3 | 35% | 2% | 7 |
6 | THRESHOLD MEDIATED MECHANISMS | 3 | 60% | 1% | 3 |
7 | ETHYL METHANESULFONATE | 2 | 10% | 5% | 20 |
8 | METHANESULFONIC ACID ESTERS | 2 | 67% | 1% | 2 |
9 | 1 3 DIISOPROPYLUREA | 1 | 50% | 1% | 2 |
10 | PHARMACEUTICAL INGREDIENTS APIS | 1 | 100% | 1% | 2 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Strategies for the identification, control and determination of genotoxic impurities in drug substances: A pharmaceutical industry perspective | 2011 | 23 | 36 | 69% |
Control of Genotoxic Impurities in Active Pharmaceutical Ingredients: A Review and Perspective | 2010 | 42 | 41 | 54% |
Control and analysis of alkyl esters of alkyl and aryl sulfonic acids in novel active pharmaceutical ingredients (APIs) | 2008 | 39 | 10 | 90% |
Toxicological overview of impurities in pharmaceutical products | 2007 | 37 | 2 | 100% |
Recent advances in trace analysis of pharmaceutical genotoxic impurities | 2010 | 39 | 69 | 36% |
A Systematic Method Development Strategy for Determination of Pharmaceutical Genotoxic Impurities | 2010 | 14 | 19 | 63% |
Potential thresholds for genotoxic effects by micronucleus scoring | 2011 | 15 | 38 | 42% |
Assessment of mechanisms driving non-linear dose-response relationships in genotoxicity testing | 2015 | 1 | 175 | 14% |
Review of Quality Deficiencies Found in Active Phamaceutical Ingredient Master Files Submitted to the WHO Prequalification of Medicines Programme | 2014 | 0 | 1 | 100% |
Control and analysis of alkyl and benzyl halides and other related reactive organohalides as potential genotoxic impurities in active pharmaceutical ingredients (APIs) | 2008 | 37 | 24 | 38% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | CHICAGO PHARMACEUT SCI GRP | 3 | 100% | 0.8% | 3 |
2 | DRUG DISPOSIT PRECLIN SAFETY ANIM | 2 | 67% | 0.5% | 2 |
3 | VITRY ALFORTVILLE | 2 | 40% | 1.1% | 4 |
4 | ESTABLISHED PHARMACEUT | 1 | 50% | 0.5% | 2 |
5 | PHARM SCI TECH | 1 | 100% | 0.5% | 2 |
6 | R45T | 1 | 100% | 0.5% | 2 |
7 | US I PROC DEV | 1 | 100% | 0.5% | 2 |
8 | PULM ALLERGY PROD | 1 | 33% | 0.5% | 2 |
9 | ANALYT QUAL SERV | 1 | 50% | 0.3% | 1 |
10 | BUNDES ARZNEIMITTEL MED PROD BFARM | 1 | 50% | 0.3% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000242276 | THRESHOLD OF TOXICOLOGICAL CONCERN//THRESHOLD OF TOXICOLOGICAL CONCERN TTC//EXPOSURE BASED WAIVING |
2 | 0.0000155602 | MOUSE LYMPHOMA ASSAY//DGRT//L5178Y MOUSE LYMPHOMA CELL |
3 | 0.0000136615 | TD50//MC4PC//RODENT CARCINOGENICITY BIOASSAY |
4 | 0.0000126968 | LIVER MICRONUCLEUS ASSAY//CD71 ANTIGEN//IWGT |
5 | 0.0000077321 | LACI//MUTA TM MOUSE//LACL |
6 | 0.0000074316 | DIBROMANTIN//1 3 DIBROMO 5 5 DIMETHYL 2 4 IMIDAZOLIDINEDIONE 77 48 5//BETA KETO CARBONYL COMPOUNDS |
7 | 0.0000072682 | ETHYLENE OXIDE//HEMOGLOBIN ADDUCTS//HYDROXYETHYLVALINE |
8 | 0.0000068391 | MICRONUCLEI//MICRONUCLEUS//BUCCAL MUCOSA CELLS |
9 | 0.0000061776 | ORGANIC SOLVENT NANOFILTRATION//SOLVENT RESISTANT NANOFILTRATION//ORGANIC SOLVENT NANOFILTRATION OSN |
10 | 0.0000059772 | BENCHMARK DOSE//INTRALITTER CORRELATION//EXCHANGEABLE BINARY DATA |